Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: A case-control study

Epidemiology and Infection

Volumn 134, Issue 6, 2006, Pages 1169-1173

  Carnicer Pont, D ^a   Bailey, K A ^a   Mason, Brendan W ^a   Walker, A M ^a   Evans, M R ^a,b   Salmon, R L ^a  

^a PUBLIC HEALTH WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD SAMPLING; BLOOD TRANSFUSION; CATHETER INFECTION; CATHETERIZATION; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DECUBITUS; DRUG USE; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INDWELLING CATHETER; INFECTION CONTROL; INFECTION RISK; LENGTH OF STAY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RISK FACTOR; SEX DIFFERENCE; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; UNITED KINGDOM; URINE CATHETER; CASE CONTROL STUDY; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CROSS INFECTION; DRUG EFFECT; MICROBIOLOGY; PENICILLIN RESISTANCE; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS;

BACTEREMIA; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33750339722     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006327     Document Type: Article

References (31)

1. National Audit Office. Improving patient care by reducing the risk of hospital acquired infection: A progress report. Report by the Comptroller and Auditor General - HC 876 Session 2003-2004. London, UK: National Audit Office, 2004.
2. European Antimicrobial Resistance Surveillance System. Annual Report 2002. Bilthoven, Netherlands: National Institute of Public Health and the Environment, 2003.
3. Reacher MH, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: Trend analysis. British Medical Journal 2000; 320: 213-216.
4. Public Health Laboratory Service. Staphylococcus aureus bacteraemia: England, Wales and Northern Ireland, January to December 2002. Communicable Disease Report CDR Weekly (serial online) 2003 (cited 23 July 2004); 13: Bacteraemia.
5. Health Protection Agency. The third year of regional and national analyses of the Department of Health's mandatory MRSA surveillance scheme in England: April 2001-March 2004. Communicable Disease Report CDR Weekly (serial online) 2004 (cited 23 July 2004); 14: Bacteraemia.
6. National Public Health Service for Wales. Staphylococcus aureus Bacteraemia Surveillance 11th Report. Cardiff, UK: NPHS Communicable Disease Surveillance Centre, 2004.
7. Coello R, et al. Device-related sources of bacteraemia in English hospitals - opportunities for the prevention of hospital-acquired bacteraemia. Journal Hospital Infection 2003; 53: 46-57.
8. National Public Health Service for Wales. Staphylococcus aureus Bacteraemia Surveillance 10th Report. Cardiff, UK: NPHS Communicable Disease Surveillance Centre, 2003.
9. Crowcroft N, et al. Methicillin-resistant Staphylococcus aureus: investigation of a hospital outbreak using a case control study. Journal of Hospital Infection 1996; 34: 301-309.
10. Jensen AG, et al. Risk factors, for hospital acquired Staphylococus aureus bacteraemia. Archives of Internal Medicine 1999; 159: 1437-1443.
11. Tacconelli E, et al. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: Distinguishing between community-acquired versus healthcare-associated strains. Journal of Antimicrobial Chemotherapy 2004; 53: 474-479.
12. Pujol M, et al. Risk factors for nosocomial bacteraemia. due to methicillin resistant Staphylococcus aureus. European Journal of Clinical Microbiology and Infectious Diseases 1994; 13: 96-102.
13. Selvey LA, Whitby M, Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: Is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infection Control and Hospital Epidemiology 2000; 21: 645-648.
14. Tumbarello M, et al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus bacteraemia in HIV-infected patients. Journal of Antimicrobial Chemotherapy 2602; 50: 375-382.
15. Cordova SP, et al. Methicillin-resistant Staphylococcus aureus bacteraemia in Western Australian teaching hospitals, 1997-1999: Risk factors, outcomes and implications for management. Journal of Hospital Infection 2004; 56: 22-28.
16. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. Journal of Antimicrobial Chemotherapy 2002: 49; 999-1005.
17. Washio M, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital. Public Health 1997; 111: 187-190.
18. Dziekan G, et al. Methicillin-resistant Staphylococcus aureus in a teaching hospital: Investigation of nosocomial transmission using a matched case-control study. Journal of Hospital Infection 2000; 46: 263-270.
19. Scudeller L, et al. MRSA carriage: The relationship between community and healthcare setting. A study in an Italian hospital. Journal of Hospital Infection 2000; 46: 222-229.
20. Asensio A, et al. Colonization and infection with methicillin-resistant Staphylococcus aureus: Associated factors and eradication. Infection Control and Hospital Epidemiology 1996; 17: 20-28.
21. Corea E, de Silva T, Perera J. Methicillin-resistant Staphylococcus aureus: Prevalence, incidence and risk factors associated with colonization in Sri Lanka. Journal of Hospital Infection 2003; 55: 145-148.
22. Jernigan JA, et al. Prevalence of and risk factors for colonisation with methicillin resistant Staphylococcus aureus at the time of hospital admission. Infection Control and Hospital Epidemiology 2003; 24: 409-414.
23. Jernigan JA, et al. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population. Infection Control and Hospital Epidemiology 2003; 24: 445-450.
24. Young LS, Perdreau-Remington F, Winston LG. Clinical, epidemiologic, and molecular evaluation of a clonal outbreak of methicillin-resistant Staphylococcus aureaus infection. Clinical Infectious Disease 2004; 38: 1075-1083.
25. Troillet N, et al. Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infection Control and Hospital Epidemiology 1998; 19: 181-185.
26. Laupland KB, et al. Population based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. Journal of Infectious Diseases 2003; 187: 1452-1459.
27. Morgan M, et al. The population impact of MRSA in a country: The national survey of MRSA in Wales, 1997. Journal of Hospital Infection 2000: 44: 227-239.
28. Vaudaux P, Schrenzel J. Nosocomial bacteraemia caused by Staphylococcus aureus. Lancet 2004; 364: 644-645.
29. von Eiff C, et al. Nasal carriage as a source of Staphylococcus aureus bacteraemia. New England Journal of Medicine 2001; 344: 11-16.
30. Wertheim HF, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364: 703-705.
31. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. Journal of Antimicrobial Chemotherapy 2005; 56: 455-462.